Cargando…
Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a chronic, progressive liver disease with an increasing incidence rate. This study investigated the protective effects of live combined Bacillus subtilis and Enterococcus faecium (LCBE) on NAFLD, and its possible mechanisms. MATERIAL/METHODS:...
Autores principales: | Jiang, Jie, Xiong, Jie, Ni, Jianbo, Chen, Congying, Wang, Kezhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428156/ https://www.ncbi.nlm.nih.gov/pubmed/34482357 http://dx.doi.org/10.12659/MSM.931143 |
Ejemplares similares
-
miR-148a-3p regulates alcoholic liver fibrosis through targeting ERBB3
por: Xiong, Jie, et al.
Publicado: (2020) -
Dietary Bacillus subtilis supplementation alleviates alcohol-induced liver injury by maintaining intestinal integrity and gut microbiota homeostasis in mice
por: Zhao, Meiqi, et al.
Publicado: (2021) -
Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats
por: Shen, Shu-Hua, et al.
Publicado: (2020) -
Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016) -
Effect of probiotic Enterococcus faecium SF68 on liver function in healthy dogs
por: Lucena, Rosario, et al.
Publicado: (2019)